Effects of Routine Physical Therapy With and Without Neurodevelopmental Technique on GMF, Spasticity and HRQOL in Diplegic CP
Launched by UNIVERSITY OF LAHORE · May 30, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
The neurological illness known as cerebral palsy is caused by damage to the growing brain and therefore is indicated by anomalies of muscle strength, mobility, and motor functions. Cerebral palsy affects posture, muscle tone, and movement development. Neurodevelopmental technique and routine physical therapy are considered to be effective in treatment of cerebral palsy. This study will investigate the combined effects of neurodevelopmental technique and routine physical therapy versus routine physical therapy on gross motor function, spasticity, and health related quality of life in diplegi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with an age of 8 to 18 years of both genderswith confirm diagnosis of diplegic cerebral palsy
- • Patients could ambulate functionally
- • Patients having limited or no prior exposure to NDT
- • Individuals with mild to moderate diplegic cerebral palsy, based on established classification scales (GMFM grade I-III)
- Exclusion Criteria:
- • Patients with other motor or sensory dysfunctions and unable to understand and obey commands
- • Patient undergone any orthopedic surgery that was ought to treatspasticity
- • Patients with spasticity level 4-5 according to Modified Ashworth Scale
- • Patients with Botulinum toxins type A injection within last 6 months
Trial Officials
Shehzeena Ashraf
Study Chair
University of Lahore
About University Of Lahore
The University of Lahore is a leading academic institution dedicated to advancing healthcare research and education. With a robust commitment to scientific inquiry, the university sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Leveraging its state-of-the-art facilities and interdisciplinary expertise, the University of Lahore collaborates with healthcare professionals and researchers to conduct innovative studies that address pressing health challenges. Through its clinical trial initiatives, the university strives to contribute to evidence-based practices and foster advancements in clinical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0